Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
Featured Image

Breaking in the Spring with the Chapter’s Golf Outing

  • Posted by Dan Kenny
  • On May 16, 2017
On May 8th, the ISPE Boston Area Chapter’s Social Committee hosted the Annual Spring Golf Outing at Ledgemont Country Club in Seekonk, MA. With the event sold out, ISPE Chapter members and guests braved the blustering wind and enjoyed an invigorating day of golf. Although the sun was in and out all day, the rain […]
Read More
 
 Featured Image

First New Treatment for ALS in More Than 20 Years Approved by FDA

  • Posted by jwillard
  • On May 11, 2017
MT Pharma America announced that the FDA has granted approval of Radicava (edaravone) to treat amyotrophic lateral sclerosis (ALS). ALS is a rapidly progressive neurodegenerative disease – the majority of patients die within two to five years of diagnosis. An estimated 6,000 Americans are diagnosed each year with ALS, an incurable disease that affects the […]
Read More
 

Magenta Therapeutics Adds $50 Million for Stem Cell Development

  • Posted by Janet Tice
  • On May 11, 2017
Cambridge-based Magenta Therapeutics, a biotech company developing therapies to improve and expand the use of curative stem cell transplantation, has announced completion of a $50 million Series B financing; in-licensing of a clinical-stage program from Novartis to support the use of stem cell transplantation in a variety of disease settings; and a strategic partnership with […]
Read More
 

Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

  • Posted by Janet Tice
  • On May 11, 2017
At the end of April, Biogen reported first quarter 2017 financial results, including worldwide revenues of $47 million for Spinraza, a drug approved by the FDA in December 2016 for treatment of spinal muscular atrophy (SMA). “I am very pleased with the results of the first quarter. We saw continued stability in our MS business, […]
Read More
 
 Featured Image

Student Poster Contest Winners Earn $500 and Free Trip to ISPE Annual Meeting!

  • Posted by Brian Hagopian
  • On May 11, 2017
The Chapter held its annual Student Poster Contest at WPI on April 13th in conjunction with the Chapter’s monthly educational program on single use technologies. Students set up their posters in WPI’s pilot manufacturing facility where they had the opportunity to see state-of-the-art equipment in operation while meeting and networking with over 50 ISPE professionals. […]
Read More
 
 Featured Image

Survey Results Prove Product Show’s Success

  • Posted by H. Steven Kennedy
  • On May 9, 2017
Anyone who attended the 2016 Product Show knows it was another home run for the Chapter. But that’s not enough for the Product Show Committee. In order to ensure that we continue to deliver the best possible Show for exhibitors and attendees, the committee surveyed both groups and the overall results confirmed that the Show […]
Read More
 
 Featured Image

Chapter’s Anniversary Gala Celebrates 25 Years of Success

  • Posted by John Spohn
  • On May 4, 2017
It was THRILLING to host the Boston Area Chapter 25th Anniversary Gala.  When we decide to go big, we go BIG!  The gussied-up crowd, the glittering venue, fine dining and live music were the appropriate frame to recognize the founders and the positive force the Chapter has become. The event, sold out several weeks in […]
Read More
 

ISPE and PDA Talk Shop with Validation Experts at Joint Meeting

  • Posted by ispeblog
  • On May 2, 2017
The ISPE Boston Area Chapter and the PDA New England Chapter are joining forces to present “Validation: The Bridge Between Engineering & Quality Assurance” on May 17. Don’t miss this unique opportunity to exchange ideas with an expanded industry cross section and hear from industry experts Sylvan Poeckh and Paul Stanovich on “The Role and […]
Read More
 
 Featured Image

Sanofi and Lonza Partner to Build Biologics Production Facility in Switzerland

  • Posted by jwillard
  • On April 28, 2017
Lonza has announced that they will partner with Sanofi to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The initial investment will be around CHF 290 million (€ 270 million), to be split equally between the companies. The initial phase of the facility will commence construction in […]
Read More
 

Biogen Licenses Potential Alzheimer’s Drug from Bristol-Myers Squibb

  • Posted by Janet Tice
  • On April 28, 2017
Biogen has announced an agreement to exclusively license an experimental medicine with potential to treat Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP) from Bristol-Myers Squibb. The drug, known as BMS-986168, is an antibody targeting extracellular tau, the protein that forms the deposits, or tangles, in the brain associated with AD and other neurodegenerative tauopathies […]
Read More